pillbase.ru

Tymlos

Active substance: abaloparatide

INJECTION, SOLUTION · ABALOPARATIDE 3.12 mg/1.56mL

United StatesActive

Marketing holder: Radius Health, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Eladynos
    abaloparatide
    EMEA/H/C/005928
    Theramex Ireland Limited
  • Eladynos
    abaloparatide
    EMEA/H/C/004157
    Radius Health Ireland Ltd
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-b828-7919-8ded-db53556ed40f;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
70539-001
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 70539-001 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 70539-001 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 70539-001 · Verified 2026-10-09 · open in source